Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

Kodai Suzuki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1861-7394; OpenAlex author ID A5032302700. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Targeting the αvβ5 Integrin Modifies the TGFβ-Rich Tumor Microenvironment of Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-4223↗
  2. A pancreatic cancer mouse model with human immunity First author DOI 10.1101/2023.05.24.542127↗
  3. Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker Co-author DOI 10.1101/2023.05.24.542137↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kazuki N. Sugahara · 3 shared papers, 2023–2026 · strength 0.61
  2. Norio Miyamura · 3 shared papers, 2023–2026 · strength 0.61
  3. Andrew M. Lowy · 3 shared papers, 2023–2026 · strength 0.61
  4. Tatiana Hurtado de Mendoza · 2 shared papers, 2023–2026 · strength 0.43
  5. Yukihito Kuroda · 2 shared papers, 2023–2026 · strength 0.43

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.